Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Share-based Compensation: 2021-2025

Historic Share-based Compensation for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to $18.6 million.

  • MDxHealth's Share-based Compensation rose 13.27% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.4 million, marking a year-over-year increase of 66.71%. This contributed to the annual value of $1.7 million for FY2024, which is 159.40% up from last year.
  • Latest data reveals that MDxHealth reported Share-based Compensation of $18.6 million as of Q3 2025, which was up 2.46% from $18.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Share-based Compensation registered a high of $18.6 million during Q3 2025, and its lowest value of -$15.4 million during Q2 2024.
  • In the last 3 years, MDxHealth's Share-based Compensation had a median value of $12.1 million in 2023 and averaged $7.6 million.
  • Per our database at Business Quant, MDxHealth's Share-based Compensation crashed by 3,127.44% in 2023 and then soared by 218.16% in 2025.
  • MRQ analysis of 5 years shows MDxHealth's Share-based Compensation stood at $10.6 million in 2021, then grew by 8.17% to $11.5 million in 2022, then increased by 5.80% to $12.1 million in 2023, then skyrocketed by 41.07% to $17.1 million in 2024, then grew by 8.86% to $18.6 million in 2025.
  • Its Share-based Compensation stands at $18.6 million for Q3 2025, versus $18.2 million for Q2 2025 and $391,000 for Q1 2025.